The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Asset management agreement and transactional structuring for an investment advisory service company
Assisted an investment advisory service company with its asset management agreement for a complex, multibillion dollar transaction involving a more
Private investments for a major institutional investor
Represented a major institutional investor in connection with over 30 investments, with an aggregate value of nearly $3 billion, in various private more
Construction litigation for a general contractor
Represent a general contractor in complex litigation involving the construction of an approximately $13 million long-term, acute care hospital in more
Trademark counsel to Putt-Putt LLC
Represents Putt-Putt LLC, an entertainment franchise company, as counsel on all aspects of the company’s business, including licensing of the more